JoAnn Flaim

Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial

Frederick J. Raal, Raúl D. Santos, Dirk Blom et al. · The Lancet · 2010 · 897 citations

Homozygous Familial Hypercholesterolaemia, Oxysterol, Cardiovascular Disease +7

Mipomersen, an Apolipoprotein B Synthesis Inhibitor, Reduces Atherogenic Lipoproteins in Patients With Severe Hypercholesterolemia at High Cardiovascular Risk

Gregory S. Thomas, William C. Cromwell, Shariq Ali et al. · Journal of the American College of Cardiology · 2013 · 243 citations

Metabolic Syndrome, Oxysterol, Cardiovascular Disease +11

Effect of Mipomersen, an Apolipoprotein B Synthesis Inhibitor, on Low-Density Lipoprotein Cholesterol in Patients With Familial Hypercholesterolemia

Fatima Akdim, Maartje E. Visser, Diane L. Tribble et al. · The American Journal of Cardiology · 2010 · 178 citations

Metabolic Syndrome, Familial Hypercholesterolemia, Oxysterol +7

Efficacy and Safety of Mipomersen, an Antisense Inhibitor of Apolipoprotein B, in Hypercholesterolemic Subjects Receiving Stable Statin Therapy

Fatima Akdim, Erik S.G. Stroes, Eric J.G. Sijbrands et al. · Journal of the American College of Cardiology · 2010 · 160 citations

Antisense Inhibitor, Oxysterol, Cardiovascular Disease +7

Efficacy of apolipoprotein B synthesis inhibition in subjects with mild-to-moderate hyperlipidaemia

Fatima Akdim, Diane L. Tribble, JoAnn Flaim et al. · European Heart Journal · 2011 · 123 citations